nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—CYP1A1—kidney cancer	0.332	1	CbGaD
Riluzole—ABCG2—Pazopanib—kidney cancer	0.0591	0.146	CbGbCtD
Riluzole—ABCG2—Dactinomycin—kidney cancer	0.054	0.133	CbGbCtD
Riluzole—ABCG2—Erlotinib—kidney cancer	0.0422	0.104	CbGbCtD
Riluzole—CYP1A1—Erlotinib—kidney cancer	0.0389	0.0961	CbGbCtD
Riluzole—ABCG2—Paclitaxel—kidney cancer	0.0386	0.0953	CbGbCtD
Riluzole—ABCG2—Sorafenib—kidney cancer	0.0343	0.0847	CbGbCtD
Riluzole—ABCG2—Vincristine—kidney cancer	0.0333	0.0822	CbGbCtD
Riluzole—ABCG2—Sunitinib—kidney cancer	0.0278	0.0686	CbGbCtD
Riluzole—CYP1A2—Pazopanib—kidney cancer	0.0244	0.0602	CbGbCtD
Riluzole—ABCG2—Doxorubicin—kidney cancer	0.0208	0.0514	CbGbCtD
Riluzole—CYP1A2—Erlotinib—kidney cancer	0.0174	0.0429	CbGbCtD
Riluzole—CYP1A2—Sorafenib—kidney cancer	0.0141	0.0349	CbGbCtD
Riluzole—SLC7A11—Hemostasis—ITPR2—kidney cancer	0.000142	0.00276	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HNF1A—kidney cancer	0.000133	0.00259	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—EPAS1—kidney cancer	0.000133	0.00259	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000132	0.00258	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—HIF1A—kidney cancer	0.000128	0.0025	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—ALDH1A1—kidney cancer	0.000128	0.00249	CbGpPWpGaD
Riluzole—CYP1A2—Estrogen Receptor Pathway—JUN—kidney cancer	0.000122	0.00239	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS1—kidney cancer	0.00012	0.00235	CbGpPWpGaD
Riluzole—CYP1A2—Melatonin metabolism and effects—CYP1A1—kidney cancer	0.00012	0.00234	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000115	0.00224	CbGpPWpGaD
Riluzole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000115	0.00224	CbGpPWpGaD
Riluzole—ABCG2—HIF-2-alpha transcription factor network—VEGFA—kidney cancer	0.000115	0.00224	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—KRAS—kidney cancer	0.000114	0.00223	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—kidney cancer	0.000113	0.00221	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—HNF1B—kidney cancer	0.000108	0.00211	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—HIF1A—kidney cancer	0.000105	0.00205	CbGpPWpGaD
Riluzole—SLC7A11—Cell surface interactions at the vascular wall—PIK3CA—kidney cancer	0.000105	0.00205	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IFNA1—kidney cancer	0.000104	0.00203	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—kidney cancer	0.000103	0.00201	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IFNA2—kidney cancer	9.67e-05	0.00189	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC5A5—kidney cancer	9.61e-05	0.00188	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—SLC2A1—kidney cancer	9.29e-05	0.00181	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—PAK1—kidney cancer	9.01e-05	0.00176	CbGpPWpGaD
Riluzole—ABCG2—Fluoropyrimidine Activity—TP53—kidney cancer	8.87e-05	0.00173	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—IGF2—kidney cancer	8.71e-05	0.0017	CbGpPWpGaD
Riluzole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CRABP1—kidney cancer	8.53e-05	0.00167	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	8.44e-05	0.00165	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—kidney cancer	8.3e-05	0.00162	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—kidney cancer	8.3e-05	0.00162	CbGpPWpGaD
Riluzole—CYP1A2—Tryptophan metabolism—CYP1A1—kidney cancer	8.3e-05	0.00162	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTT1—kidney cancer	8.18e-05	0.0016	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—ALDH1A1—kidney cancer	8.14e-05	0.00159	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	8e-05	0.00156	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—RELA—kidney cancer	7.96e-05	0.00155	CbGpPWpGaD
Riluzole—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—kidney cancer	7.88e-05	0.00154	CbGpPWpGaD
Riluzole—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	7.84e-05	0.00153	CbGpPWpGaD
Riluzole—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	7.76e-05	0.00152	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CTNNA1—kidney cancer	7.75e-05	0.00151	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	7.74e-05	0.00151	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—MAPK3—kidney cancer	7.74e-05	0.00151	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—JUN—kidney cancer	7.72e-05	0.00151	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTT1—kidney cancer	7.5e-05	0.00146	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PAX6—kidney cancer	7.42e-05	0.00145	CbGpPWpGaD
Riluzole—SCN5A—L1CAM interactions—MAPK1—kidney cancer	7.36e-05	0.00144	CbGpPWpGaD
Riluzole—SLC7A11—Transmembrane transport of small molecules—ABCB1—kidney cancer	7.33e-05	0.00143	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	7.33e-05	0.00143	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	7.33e-05	0.00143	CbGpPWpGaD
Riluzole—CYP1A1—Arachidonic acid metabolism—PTGS2—kidney cancer	7.24e-05	0.00141	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	7.17e-05	0.0014	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—PTGS1—kidney cancer	7.03e-05	0.00137	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	6.98e-05	0.00136	CbGpPWpGaD
Riluzole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—kidney cancer	6.75e-05	0.00132	CbGpPWpGaD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	6.71e-05	0.00131	CbGpPWpGaD
Riluzole—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	6.62e-05	0.00129	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC5A3—kidney cancer	6.6e-05	0.00129	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ANXA2—kidney cancer	6.6e-05	0.00129	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—ATP7B—kidney cancer	6.6e-05	0.00129	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—PAK1—kidney cancer	6.43e-05	0.00126	CbGpPWpGaD
Riluzole—CYP1A1—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.36e-05	0.00124	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—JUN—kidney cancer	6.35e-05	0.00124	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	6.3e-05	0.00123	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	6.2e-05	0.00121	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	6.1e-05	0.00119	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ACY1—kidney cancer	5.89e-05	0.00115	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	5.67e-05	0.00111	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—KDR—kidney cancer	5.61e-05	0.0011	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—MYC—kidney cancer	5.61e-05	0.00109	CbGpPWpGaD
Riluzole—SCN5A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	5.55e-05	0.00108	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—MET—kidney cancer	5.49e-05	0.00107	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	5.49e-05	0.00107	CbGpPWpGaD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.44e-05	0.00106	CbGpPWpGaD
Riluzole—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	5.21e-05	0.00102	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—GSTP1—kidney cancer	5.2e-05	0.00102	CbGpPWpGaD
Riluzole—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	5.18e-05	0.00101	CbGpPWpGaD
Riluzole—CYP1A1—Metapathway biotransformation—GSTP1—kidney cancer	5.13e-05	0.001	CbGpPWpGaD
Riluzole—Oedema—Paclitaxel—kidney cancer	5.11e-05	0.000241	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	5.1e-05	0.000996	CbGpPWpGaD
Riluzole—Body temperature increased—Vincristine—kidney cancer	5.08e-05	0.00024	CcSEcCtD
Riluzole—Abdominal pain—Vincristine—kidney cancer	5.08e-05	0.00024	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	5.08e-05	0.000991	CbGpPWpGaD
Riluzole—Liver function test abnormal—Doxorubicin—kidney cancer	5.08e-05	0.000239	CcSEcCtD
Riluzole—Infection—Paclitaxel—kidney cancer	5.07e-05	0.000239	CcSEcCtD
Riluzole—Flatulence—Capecitabine—kidney cancer	5.06e-05	0.000239	CcSEcCtD
Riluzole—Dysgeusia—Capecitabine—kidney cancer	5.03e-05	0.000237	CcSEcCtD
Riluzole—Dizziness—Sunitinib—kidney cancer	5.03e-05	0.000237	CcSEcCtD
Riluzole—Feeling abnormal—Gemcitabine—kidney cancer	5.03e-05	0.000237	CcSEcCtD
Riluzole—Shock—Paclitaxel—kidney cancer	5.02e-05	0.000237	CcSEcCtD
Riluzole—Vomiting—Sorafenib—kidney cancer	5.02e-05	0.000237	CcSEcCtD
Riluzole—Orthostatic hypotension—Doxorubicin—kidney cancer	5.02e-05	0.000237	CcSEcCtD
Riluzole—Nervous system disorder—Paclitaxel—kidney cancer	5.01e-05	0.000236	CcSEcCtD
Riluzole—ABCG2—Metabolism—PDHB—kidney cancer	5.01e-05	0.000977	CbGpPWpGaD
Riluzole—Hypokalaemia—Doxorubicin—kidney cancer	5e-05	0.000236	CcSEcCtD
Riluzole—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5e-05	0.000976	CbGpPWpGaD
Riluzole—Thrombocytopenia—Paclitaxel—kidney cancer	5e-05	0.000236	CcSEcCtD
Riluzole—Tachycardia—Paclitaxel—kidney cancer	4.98e-05	0.000235	CcSEcCtD
Riluzole—Rash—Sorafenib—kidney cancer	4.98e-05	0.000235	CcSEcCtD
Riluzole—Dermatitis—Sorafenib—kidney cancer	4.98e-05	0.000235	CcSEcCtD
Riluzole—Back pain—Capecitabine—kidney cancer	4.97e-05	0.000234	CcSEcCtD
Riluzole—Breast disorder—Doxorubicin—kidney cancer	4.97e-05	0.000234	CcSEcCtD
Riluzole—Skin disorder—Paclitaxel—kidney cancer	4.96e-05	0.000234	CcSEcCtD
Riluzole—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.95e-05	0.000233	CcSEcCtD
Riluzole—Headache—Sorafenib—kidney cancer	4.95e-05	0.000233	CcSEcCtD
Riluzole—Muscle spasms—Capecitabine—kidney cancer	4.94e-05	0.000233	CcSEcCtD
Riluzole—Hyperhidrosis—Paclitaxel—kidney cancer	4.94e-05	0.000233	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	4.93e-05	0.000963	CbGpPWpGaD
Riluzole—Diarrhoea—Dactinomycin—kidney cancer	4.92e-05	0.000232	CcSEcCtD
Riluzole—Anorexia—Paclitaxel—kidney cancer	4.87e-05	0.000229	CcSEcCtD
Riluzole—Gastritis—Doxorubicin—kidney cancer	4.86e-05	0.000229	CcSEcCtD
Riluzole—Muscular weakness—Doxorubicin—kidney cancer	4.85e-05	0.000229	CcSEcCtD
Riluzole—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.85e-05	0.000229	CcSEcCtD
Riluzole—Vomiting—Sunitinib—kidney cancer	4.83e-05	0.000228	CcSEcCtD
Riluzole—Body temperature increased—Gemcitabine—kidney cancer	4.82e-05	0.000227	CcSEcCtD
Riluzole—Tremor—Capecitabine—kidney cancer	4.81e-05	0.000227	CcSEcCtD
Riluzole—Rash—Sunitinib—kidney cancer	4.79e-05	0.000226	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—RAF1—kidney cancer	4.79e-05	0.000935	CbGpPWpGaD
Riluzole—Dermatitis—Sunitinib—kidney cancer	4.79e-05	0.000226	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTT1—kidney cancer	4.78e-05	0.000934	CbGpPWpGaD
Riluzole—Abdominal distension—Doxorubicin—kidney cancer	4.78e-05	0.000225	CcSEcCtD
Riluzole—CYP1A1—Biological oxidations—GSTM1—kidney cancer	4.78e-05	0.000933	CbGpPWpGaD
Riluzole—Hypotension—Paclitaxel—kidney cancer	4.77e-05	0.000225	CcSEcCtD
Riluzole—Ill-defined disorder—Capecitabine—kidney cancer	4.76e-05	0.000225	CcSEcCtD
Riluzole—Headache—Sunitinib—kidney cancer	4.76e-05	0.000224	CcSEcCtD
Riluzole—Dysphagia—Doxorubicin—kidney cancer	4.75e-05	0.000224	CcSEcCtD
Riluzole—Asthma—Doxorubicin—kidney cancer	4.75e-05	0.000224	CcSEcCtD
Riluzole—Influenza—Doxorubicin—kidney cancer	4.75e-05	0.000224	CcSEcCtD
Riluzole—Anaemia—Capecitabine—kidney cancer	4.75e-05	0.000224	CcSEcCtD
Riluzole—Hypersensitivity—Vincristine—kidney cancer	4.74e-05	0.000223	CcSEcCtD
Riluzole—CYP1A1—Metapathway biotransformation—GSTM1—kidney cancer	4.71e-05	0.00092	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CCBL1—kidney cancer	4.71e-05	0.000919	CbGpPWpGaD
Riluzole—Nausea—Sorafenib—kidney cancer	4.69e-05	0.000221	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	4.67e-05	0.000912	CbGpPWpGaD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	4.67e-05	0.000912	CbGpPWpGaD
Riluzole—Pancreatitis—Doxorubicin—kidney cancer	4.66e-05	0.00022	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.65e-05	0.000219	CcSEcCtD
Riluzole—Malaise—Capecitabine—kidney cancer	4.63e-05	0.000218	CcSEcCtD
Riluzole—Angina pectoris—Doxorubicin—kidney cancer	4.63e-05	0.000218	CcSEcCtD
Riluzole—Insomnia—Paclitaxel—kidney cancer	4.62e-05	0.000218	CcSEcCtD
Riluzole—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	4.62e-05	0.000901	CbGpPWpGaD
Riluzole—Vertigo—Capecitabine—kidney cancer	4.61e-05	0.000217	CcSEcCtD
Riluzole—Asthenia—Vincristine—kidney cancer	4.61e-05	0.000217	CcSEcCtD
Riluzole—Syncope—Capecitabine—kidney cancer	4.61e-05	0.000217	CcSEcCtD
Riluzole—Leukopenia—Capecitabine—kidney cancer	4.6e-05	0.000217	CcSEcCtD
Riluzole—Paraesthesia—Paclitaxel—kidney cancer	4.59e-05	0.000216	CcSEcCtD
Riluzole—Vomiting—Dactinomycin—kidney cancer	4.58e-05	0.000216	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	4.57e-05	0.000893	CbGpPWpGaD
Riluzole—Bronchitis—Doxorubicin—kidney cancer	4.57e-05	0.000215	CcSEcCtD
Riluzole—Dyspnoea—Paclitaxel—kidney cancer	4.55e-05	0.000215	CcSEcCtD
Riluzole—Somnolence—Paclitaxel—kidney cancer	4.54e-05	0.000214	CcSEcCtD
Riluzole—Palpitations—Capecitabine—kidney cancer	4.54e-05	0.000214	CcSEcCtD
Riluzole—Rash—Dactinomycin—kidney cancer	4.54e-05	0.000214	CcSEcCtD
Riluzole—Nausea—Sunitinib—kidney cancer	4.52e-05	0.000213	CcSEcCtD
Riluzole—Loss of consciousness—Capecitabine—kidney cancer	4.51e-05	0.000213	CcSEcCtD
Riluzole—Pancytopenia—Doxorubicin—kidney cancer	4.51e-05	0.000213	CcSEcCtD
Riluzole—Dyspepsia—Paclitaxel—kidney cancer	4.5e-05	0.000212	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—PTGS1—kidney cancer	4.48e-05	0.000875	CbGpPWpGaD
Riluzole—Cough—Capecitabine—kidney cancer	4.48e-05	0.000211	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	4.45e-05	0.000868	CbGpPWpGaD
Riluzole—Dysuria—Doxorubicin—kidney cancer	4.44e-05	0.000209	CcSEcCtD
Riluzole—Neutropenia—Doxorubicin—kidney cancer	4.44e-05	0.000209	CcSEcCtD
Riluzole—Decreased appetite—Paclitaxel—kidney cancer	4.44e-05	0.000209	CcSEcCtD
Riluzole—Hypertension—Capecitabine—kidney cancer	4.43e-05	0.000209	CcSEcCtD
Riluzole—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.41e-05	0.000208	CcSEcCtD
Riluzole—Fatigue—Paclitaxel—kidney cancer	4.4e-05	0.000208	CcSEcCtD
Riluzole—Diarrhoea—Vincristine—kidney cancer	4.4e-05	0.000207	CcSEcCtD
Riluzole—Pollakiuria—Doxorubicin—kidney cancer	4.39e-05	0.000207	CcSEcCtD
Riluzole—Asthenia—Gemcitabine—kidney cancer	4.38e-05	0.000206	CcSEcCtD
Riluzole—Arthralgia—Capecitabine—kidney cancer	4.37e-05	0.000206	CcSEcCtD
Riluzole—Chest pain—Capecitabine—kidney cancer	4.37e-05	0.000206	CcSEcCtD
Riluzole—Myalgia—Capecitabine—kidney cancer	4.37e-05	0.000206	CcSEcCtD
Riluzole—Constipation—Paclitaxel—kidney cancer	4.37e-05	0.000206	CcSEcCtD
Riluzole—Pain—Paclitaxel—kidney cancer	4.37e-05	0.000206	CcSEcCtD
Riluzole—Anxiety—Capecitabine—kidney cancer	4.36e-05	0.000205	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.34e-05	0.000205	CcSEcCtD
Riluzole—Photosensitivity reaction—Doxorubicin—kidney cancer	4.34e-05	0.000204	CcSEcCtD
Riluzole—Weight increased—Doxorubicin—kidney cancer	4.32e-05	0.000204	CcSEcCtD
Riluzole—Discomfort—Capecitabine—kidney cancer	4.32e-05	0.000204	CcSEcCtD
Riluzole—Pruritus—Gemcitabine—kidney cancer	4.32e-05	0.000203	CcSEcCtD
Riluzole—Weight decreased—Doxorubicin—kidney cancer	4.3e-05	0.000203	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—IL2—kidney cancer	4.3e-05	0.000839	CbGpPWpGaD
Riluzole—Dry mouth—Capecitabine—kidney cancer	4.28e-05	0.000202	CcSEcCtD
Riluzole—Nausea—Dactinomycin—kidney cancer	4.28e-05	0.000201	CcSEcCtD
Riluzole—Pneumonia—Doxorubicin—kidney cancer	4.26e-05	0.000201	CcSEcCtD
Riluzole—Dizziness—Vincristine—kidney cancer	4.25e-05	0.0002	CcSEcCtD
Riluzole—Infestation NOS—Doxorubicin—kidney cancer	4.24e-05	0.0002	CcSEcCtD
Riluzole—Infestation—Doxorubicin—kidney cancer	4.24e-05	0.0002	CcSEcCtD
Riluzole—Confusional state—Capecitabine—kidney cancer	4.23e-05	0.000199	CcSEcCtD
Riluzole—Feeling abnormal—Paclitaxel—kidney cancer	4.21e-05	0.000198	CcSEcCtD
Riluzole—Oedema—Capecitabine—kidney cancer	4.19e-05	0.000198	CcSEcCtD
Riluzole—Gastrointestinal pain—Paclitaxel—kidney cancer	4.18e-05	0.000197	CcSEcCtD
Riluzole—Diarrhoea—Gemcitabine—kidney cancer	4.17e-05	0.000197	CcSEcCtD
Riluzole—Infection—Capecitabine—kidney cancer	4.16e-05	0.000196	CcSEcCtD
Riluzole—Neuropathy peripheral—Doxorubicin—kidney cancer	4.15e-05	0.000196	CcSEcCtD
Riluzole—SLC7A11—Transmembrane transport of small molecules—RAF1—kidney cancer	4.15e-05	0.00081	CbGpPWpGaD
Riluzole—Jaundice—Doxorubicin—kidney cancer	4.13e-05	0.000195	CcSEcCtD
Riluzole—Stomatitis—Doxorubicin—kidney cancer	4.13e-05	0.000195	CcSEcCtD
Riluzole—Shock—Capecitabine—kidney cancer	4.12e-05	0.000194	CcSEcCtD
Riluzole—Urinary tract infection—Doxorubicin—kidney cancer	4.12e-05	0.000194	CcSEcCtD
Riluzole—Nervous system disorder—Capecitabine—kidney cancer	4.11e-05	0.000194	CcSEcCtD
Riluzole—Thrombocytopenia—Capecitabine—kidney cancer	4.1e-05	0.000193	CcSEcCtD
Riluzole—Tachycardia—Capecitabine—kidney cancer	4.09e-05	0.000193	CcSEcCtD
Riluzole—Vomiting—Vincristine—kidney cancer	4.09e-05	0.000193	CcSEcCtD
Riluzole—ABCG2—Metabolism—PPAT—kidney cancer	4.08e-05	0.000797	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GLIPR1—kidney cancer	4.08e-05	0.000797	CbGpPWpGaD
Riluzole—Skin disorder—Capecitabine—kidney cancer	4.07e-05	0.000192	CcSEcCtD
Riluzole—Sweating—Doxorubicin—kidney cancer	4.06e-05	0.000191	CcSEcCtD
Riluzole—Urticaria—Paclitaxel—kidney cancer	4.06e-05	0.000191	CcSEcCtD
Riluzole—SCN5A—Axon guidance—RAF1—kidney cancer	4.06e-05	0.000792	CbGpPWpGaD
Riluzole—Rash—Vincristine—kidney cancer	4.05e-05	0.000191	CcSEcCtD
Riluzole—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.05e-05	0.000792	CbGpPWpGaD
Riluzole—Hyperhidrosis—Capecitabine—kidney cancer	4.05e-05	0.000191	CcSEcCtD
Riluzole—Dermatitis—Vincristine—kidney cancer	4.05e-05	0.000191	CcSEcCtD
Riluzole—Haematuria—Doxorubicin—kidney cancer	4.04e-05	0.00019	CcSEcCtD
Riluzole—Body temperature increased—Paclitaxel—kidney cancer	4.04e-05	0.00019	CcSEcCtD
Riluzole—Abdominal pain—Paclitaxel—kidney cancer	4.04e-05	0.00019	CcSEcCtD
Riluzole—Headache—Vincristine—kidney cancer	4.03e-05	0.00019	CcSEcCtD
Riluzole—SCN5A—Axon guidance—ERBB2—kidney cancer	4.01e-05	0.000783	CbGpPWpGaD
Riluzole—Hepatobiliary disease—Doxorubicin—kidney cancer	4.01e-05	0.000189	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—KDR—kidney cancer	4e-05	0.000781	CbGpPWpGaD
Riluzole—Epistaxis—Doxorubicin—kidney cancer	4e-05	0.000188	CcSEcCtD
Riluzole—Anorexia—Capecitabine—kidney cancer	4e-05	0.000188	CcSEcCtD
Riluzole—CYP1A1—Metabolism—ACY1—kidney cancer	3.98e-05	0.000778	CbGpPWpGaD
Riluzole—Sinusitis—Doxorubicin—kidney cancer	3.97e-05	0.000187	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	3.95e-05	0.000772	CbGpPWpGaD
Riluzole—Agranulocytosis—Doxorubicin—kidney cancer	3.95e-05	0.000186	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—MET—kidney cancer	3.92e-05	0.000765	CbGpPWpGaD
Riluzole—Hypotension—Capecitabine—kidney cancer	3.92e-05	0.000185	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	3.89e-05	0.000759	CbGpPWpGaD
Riluzole—Vomiting—Gemcitabine—kidney cancer	3.88e-05	0.000183	CcSEcCtD
Riluzole—Bradycardia—Doxorubicin—kidney cancer	3.87e-05	0.000182	CcSEcCtD
Riluzole—Rash—Gemcitabine—kidney cancer	3.85e-05	0.000181	CcSEcCtD
Riluzole—Dermatitis—Gemcitabine—kidney cancer	3.84e-05	0.000181	CcSEcCtD
Riluzole—Haemoglobin—Doxorubicin—kidney cancer	3.82e-05	0.00018	CcSEcCtD
Riluzole—Headache—Gemcitabine—kidney cancer	3.82e-05	0.00018	CcSEcCtD
Riluzole—Nausea—Vincristine—kidney cancer	3.82e-05	0.00018	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.82e-05	0.00018	CcSEcCtD
Riluzole—Rhinitis—Doxorubicin—kidney cancer	3.81e-05	0.00018	CcSEcCtD
Riluzole—Hepatitis—Doxorubicin—kidney cancer	3.8e-05	0.000179	CcSEcCtD
Riluzole—Haemorrhage—Doxorubicin—kidney cancer	3.8e-05	0.000179	CcSEcCtD
Riluzole—ABCG2—Metabolism—FH—kidney cancer	3.79e-05	0.000741	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—APRT—kidney cancer	3.79e-05	0.000741	CbGpPWpGaD
Riluzole—Insomnia—Capecitabine—kidney cancer	3.79e-05	0.000179	CcSEcCtD
Riluzole—Hypoaesthesia—Doxorubicin—kidney cancer	3.78e-05	0.000178	CcSEcCtD
Riluzole—Pharyngitis—Doxorubicin—kidney cancer	3.77e-05	0.000178	CcSEcCtD
Riluzole—Paraesthesia—Capecitabine—kidney cancer	3.76e-05	0.000177	CcSEcCtD
Riluzole—Hypersensitivity—Paclitaxel—kidney cancer	3.76e-05	0.000177	CcSEcCtD
Riluzole—Urinary tract disorder—Doxorubicin—kidney cancer	3.76e-05	0.000177	CcSEcCtD
Riluzole—Oedema peripheral—Doxorubicin—kidney cancer	3.75e-05	0.000177	CcSEcCtD
Riluzole—Connective tissue disorder—Doxorubicin—kidney cancer	3.74e-05	0.000176	CcSEcCtD
Riluzole—Dyspnoea—Capecitabine—kidney cancer	3.74e-05	0.000176	CcSEcCtD
Riluzole—Urethral disorder—Doxorubicin—kidney cancer	3.73e-05	0.000176	CcSEcCtD
Riluzole—Dyspepsia—Capecitabine—kidney cancer	3.69e-05	0.000174	CcSEcCtD
Riluzole—Asthenia—Paclitaxel—kidney cancer	3.66e-05	0.000173	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—VEGFA—kidney cancer	3.65e-05	0.000713	CbGpPWpGaD
Riluzole—Decreased appetite—Capecitabine—kidney cancer	3.64e-05	0.000172	CcSEcCtD
Riluzole—Nausea—Gemcitabine—kidney cancer	3.62e-05	0.000171	CcSEcCtD
Riluzole—Gastrointestinal disorder—Capecitabine—kidney cancer	3.62e-05	0.000171	CcSEcCtD
Riluzole—Fatigue—Capecitabine—kidney cancer	3.61e-05	0.00017	CcSEcCtD
Riluzole—Pruritus—Paclitaxel—kidney cancer	3.61e-05	0.00017	CcSEcCtD
Riluzole—Erythema multiforme—Doxorubicin—kidney cancer	3.6e-05	0.000169	CcSEcCtD
Riluzole—Constipation—Capecitabine—kidney cancer	3.58e-05	0.000169	CcSEcCtD
Riluzole—Pain—Capecitabine—kidney cancer	3.58e-05	0.000169	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	3.58e-05	0.000698	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GPC3—kidney cancer	3.57e-05	0.000696	CbGpPWpGaD
Riluzole—Eye disorder—Doxorubicin—kidney cancer	3.55e-05	0.000168	CcSEcCtD
Riluzole—Cardiac disorder—Doxorubicin—kidney cancer	3.53e-05	0.000166	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	3.5e-05	0.000683	CbGpPWpGaD
Riluzole—Diarrhoea—Paclitaxel—kidney cancer	3.49e-05	0.000165	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.48e-05	0.00068	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CA2—kidney cancer	3.47e-05	0.000677	CbGpPWpGaD
Riluzole—Feeling abnormal—Capecitabine—kidney cancer	3.45e-05	0.000163	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—MAPK3—kidney cancer	3.45e-05	0.000674	CbGpPWpGaD
Riluzole—Angiopathy—Doxorubicin—kidney cancer	3.45e-05	0.000163	CcSEcCtD
Riluzole—Immune system disorder—Doxorubicin—kidney cancer	3.43e-05	0.000162	CcSEcCtD
Riluzole—Gastrointestinal pain—Capecitabine—kidney cancer	3.43e-05	0.000162	CcSEcCtD
Riluzole—Mediastinal disorder—Doxorubicin—kidney cancer	3.43e-05	0.000162	CcSEcCtD
Riluzole—Chills—Doxorubicin—kidney cancer	3.41e-05	0.000161	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	3.4e-05	0.000663	CbGpPWpGaD
Riluzole—Arrhythmia—Doxorubicin—kidney cancer	3.4e-05	0.00016	CcSEcCtD
Riluzole—CYP1A1—Metabolism—PDHB—kidney cancer	3.39e-05	0.000661	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ALAD—kidney cancer	3.38e-05	0.00066	CbGpPWpGaD
Riluzole—CYP1A1—Biological oxidations—POMC—kidney cancer	3.38e-05	0.000659	CbGpPWpGaD
Riluzole—Dizziness—Paclitaxel—kidney cancer	3.38e-05	0.000159	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—SLC2A1—kidney cancer	3.36e-05	0.000657	CbGpPWpGaD
Riluzole—Alopecia—Doxorubicin—kidney cancer	3.36e-05	0.000158	CcSEcCtD
Riluzole—Mental disorder—Doxorubicin—kidney cancer	3.33e-05	0.000157	CcSEcCtD
Riluzole—Urticaria—Capecitabine—kidney cancer	3.33e-05	0.000157	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTP1—kidney cancer	3.32e-05	0.000647	CbGpPWpGaD
Riluzole—Abdominal pain—Capecitabine—kidney cancer	3.31e-05	0.000156	CcSEcCtD
Riluzole—Body temperature increased—Capecitabine—kidney cancer	3.31e-05	0.000156	CcSEcCtD
Riluzole—Malnutrition—Doxorubicin—kidney cancer	3.31e-05	0.000156	CcSEcCtD
Riluzole—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	3.3e-05	0.000645	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ST3GAL2—kidney cancer	3.3e-05	0.000644	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—MAPK1—kidney cancer	3.29e-05	0.000642	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	3.27e-05	0.000638	CbGpPWpGaD
Riluzole—Flatulence—Doxorubicin—kidney cancer	3.26e-05	0.000154	CcSEcCtD
Riluzole—Tension—Doxorubicin—kidney cancer	3.25e-05	0.000153	CcSEcCtD
Riluzole—Vomiting—Paclitaxel—kidney cancer	3.25e-05	0.000153	CcSEcCtD
Riluzole—Dysgeusia—Doxorubicin—kidney cancer	3.24e-05	0.000153	CcSEcCtD
Riluzole—ABCG2—Metabolism—ALDH1A1—kidney cancer	3.23e-05	0.00063	CbGpPWpGaD
Riluzole—Rash—Paclitaxel—kidney cancer	3.22e-05	0.000152	CcSEcCtD
Riluzole—Dermatitis—Paclitaxel—kidney cancer	3.22e-05	0.000152	CcSEcCtD
Riluzole—Nervousness—Doxorubicin—kidney cancer	3.22e-05	0.000152	CcSEcCtD
Riluzole—Back pain—Doxorubicin—kidney cancer	3.2e-05	0.000151	CcSEcCtD
Riluzole—Headache—Paclitaxel—kidney cancer	3.2e-05	0.000151	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CCBL1—kidney cancer	3.19e-05	0.000622	CbGpPWpGaD
Riluzole—Muscle spasms—Doxorubicin—kidney cancer	3.18e-05	0.00015	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—KRAS—kidney cancer	3.1e-05	0.000606	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PGK1—kidney cancer	3.09e-05	0.000604	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC5A3—kidney cancer	3.09e-05	0.000604	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—VEGFA—kidney cancer	3.09e-05	0.000603	CbGpPWpGaD
Riluzole—Hypersensitivity—Capecitabine—kidney cancer	3.09e-05	0.000146	CcSEcCtD
Riluzole—Ill-defined disorder—Doxorubicin—kidney cancer	3.07e-05	0.000145	CcSEcCtD
Riluzole—Anaemia—Doxorubicin—kidney cancer	3.06e-05	0.000144	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—GSTM1—kidney cancer	3.05e-05	0.000595	CbGpPWpGaD
Riluzole—Agitation—Doxorubicin—kidney cancer	3.04e-05	0.000143	CcSEcCtD
Riluzole—Nausea—Paclitaxel—kidney cancer	3.03e-05	0.000143	CcSEcCtD
Riluzole—ABCG2—Metabolism—LDHB—kidney cancer	3.03e-05	0.000592	CbGpPWpGaD
Riluzole—Asthenia—Capecitabine—kidney cancer	3.01e-05	0.000142	CcSEcCtD
Riluzole—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	3.01e-05	0.000587	CbGpPWpGaD
Riluzole—Malaise—Doxorubicin—kidney cancer	2.99e-05	0.000141	CcSEcCtD
Riluzole—Vertigo—Doxorubicin—kidney cancer	2.97e-05	0.00014	CcSEcCtD
Riluzole—Syncope—Doxorubicin—kidney cancer	2.97e-05	0.00014	CcSEcCtD
Riluzole—Pruritus—Capecitabine—kidney cancer	2.97e-05	0.00014	CcSEcCtD
Riluzole—Leukopenia—Doxorubicin—kidney cancer	2.96e-05	0.00014	CcSEcCtD
Riluzole—Palpitations—Doxorubicin—kidney cancer	2.93e-05	0.000138	CcSEcCtD
Riluzole—SCN5A—Axon guidance—MAPK3—kidney cancer	2.92e-05	0.000571	CbGpPWpGaD
Riluzole—Loss of consciousness—Doxorubicin—kidney cancer	2.91e-05	0.000137	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—RAF1—kidney cancer	2.89e-05	0.000565	CbGpPWpGaD
Riluzole—Cough—Doxorubicin—kidney cancer	2.89e-05	0.000136	CcSEcCtD
Riluzole—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	2.89e-05	0.000564	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—RELA—kidney cancer	2.88e-05	0.000563	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.88e-05	0.000562	CbGpPWpGaD
Riluzole—Convulsion—Doxorubicin—kidney cancer	2.87e-05	0.000135	CcSEcCtD
Riluzole—Diarrhoea—Capecitabine—kidney cancer	2.87e-05	0.000135	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—ERBB2—kidney cancer	2.86e-05	0.000559	CbGpPWpGaD
Riluzole—Hypertension—Doxorubicin—kidney cancer	2.86e-05	0.000135	CcSEcCtD
Riluzole—SLC7A11—Hemostasis—PIK3CA—kidney cancer	2.85e-05	0.000557	CbGpPWpGaD
Riluzole—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	2.85e-05	0.000556	CbGpPWpGaD
Riluzole—Myalgia—Doxorubicin—kidney cancer	2.82e-05	0.000133	CcSEcCtD
Riluzole—Arthralgia—Doxorubicin—kidney cancer	2.82e-05	0.000133	CcSEcCtD
Riluzole—Chest pain—Doxorubicin—kidney cancer	2.82e-05	0.000133	CcSEcCtD
Riluzole—Anxiety—Doxorubicin—kidney cancer	2.81e-05	0.000132	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.8e-05	0.000132	CcSEcCtD
Riluzole—Discomfort—Doxorubicin—kidney cancer	2.78e-05	0.000131	CcSEcCtD
Riluzole—SCN5A—Axon guidance—MAPK1—kidney cancer	2.78e-05	0.000543	CbGpPWpGaD
Riluzole—Dizziness—Capecitabine—kidney cancer	2.77e-05	0.000131	CcSEcCtD
Riluzole—CYP1A1—Metabolism—PPAT—kidney cancer	2.76e-05	0.000539	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GLIPR1—kidney cancer	2.76e-05	0.000539	CbGpPWpGaD
Riluzole—SLC7A11—Hemostasis—TP53—kidney cancer	2.76e-05	0.000539	CbGpPWpGaD
Riluzole—Dry mouth—Doxorubicin—kidney cancer	2.76e-05	0.00013	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	2.73e-05	0.000532	CbGpPWpGaD
Riluzole—Confusional state—Doxorubicin—kidney cancer	2.72e-05	0.000128	CcSEcCtD
Riluzole—Anaphylactic shock—Doxorubicin—kidney cancer	2.7e-05	0.000127	CcSEcCtD
Riluzole—Oedema—Doxorubicin—kidney cancer	2.7e-05	0.000127	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	2.7e-05	0.000527	CbGpPWpGaD
Riluzole—Infection—Doxorubicin—kidney cancer	2.68e-05	0.000127	CcSEcCtD
Riluzole—Vomiting—Capecitabine—kidney cancer	2.66e-05	0.000126	CcSEcCtD
Riluzole—Shock—Doxorubicin—kidney cancer	2.66e-05	0.000125	CcSEcCtD
Riluzole—ABCG2—Transmembrane transport of small molecules—ABCB1—kidney cancer	2.66e-05	0.000518	CbGpPWpGaD
Riluzole—Nervous system disorder—Doxorubicin—kidney cancer	2.65e-05	0.000125	CcSEcCtD
Riluzole—Thrombocytopenia—Doxorubicin—kidney cancer	2.65e-05	0.000125	CcSEcCtD
Riluzole—Rash—Capecitabine—kidney cancer	2.64e-05	0.000125	CcSEcCtD
Riluzole—Dermatitis—Capecitabine—kidney cancer	2.64e-05	0.000124	CcSEcCtD
Riluzole—Tachycardia—Doxorubicin—kidney cancer	2.64e-05	0.000124	CcSEcCtD
Riluzole—ABCG2—Metabolism—CA9—kidney cancer	2.63e-05	0.000513	CbGpPWpGaD
Riluzole—SCN5A—Axon guidance—KRAS—kidney cancer	2.63e-05	0.000513	CbGpPWpGaD
Riluzole—Headache—Capecitabine—kidney cancer	2.63e-05	0.000124	CcSEcCtD
Riluzole—Skin disorder—Doxorubicin—kidney cancer	2.62e-05	0.000124	CcSEcCtD
Riluzole—Hyperhidrosis—Doxorubicin—kidney cancer	2.61e-05	0.000123	CcSEcCtD
Riluzole—Anorexia—Doxorubicin—kidney cancer	2.58e-05	0.000121	CcSEcCtD
Riluzole—CYP1A1—Metabolism—FH—kidney cancer	2.57e-05	0.000501	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—APRT—kidney cancer	2.57e-05	0.000501	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ACY1—kidney cancer	2.54e-05	0.000496	CbGpPWpGaD
Riluzole—Hypotension—Doxorubicin—kidney cancer	2.52e-05	0.000119	CcSEcCtD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	2.51e-05	0.00049	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—CTNNB1—kidney cancer	2.5e-05	0.000489	CbGpPWpGaD
Riluzole—Nausea—Capecitabine—kidney cancer	2.49e-05	0.000117	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.46e-05	0.000116	CcSEcCtD
Riluzole—Insomnia—Doxorubicin—kidney cancer	2.44e-05	0.000115	CcSEcCtD
Riluzole—Paraesthesia—Doxorubicin—kidney cancer	2.43e-05	0.000114	CcSEcCtD
Riluzole—CYP1A1—Metabolism—GPC3—kidney cancer	2.41e-05	0.000471	CbGpPWpGaD
Riluzole—Dyspnoea—Doxorubicin—kidney cancer	2.41e-05	0.000114	CcSEcCtD
Riluzole—Somnolence—Doxorubicin—kidney cancer	2.4e-05	0.000113	CcSEcCtD
Riluzole—Dyspepsia—Doxorubicin—kidney cancer	2.38e-05	0.000112	CcSEcCtD
Riluzole—Decreased appetite—Doxorubicin—kidney cancer	2.35e-05	0.000111	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CA2—kidney cancer	2.35e-05	0.000458	CbGpPWpGaD
Riluzole—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.33e-05	0.00011	CcSEcCtD
Riluzole—Fatigue—Doxorubicin—kidney cancer	2.33e-05	0.00011	CcSEcCtD
Riluzole—Pain—Doxorubicin—kidney cancer	2.31e-05	0.000109	CcSEcCtD
Riluzole—Constipation—Doxorubicin—kidney cancer	2.31e-05	0.000109	CcSEcCtD
Riluzole—CYP1A1—Metabolism—ALAD—kidney cancer	2.29e-05	0.000447	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CRABP1—kidney cancer	2.24e-05	0.000436	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ST3GAL2—kidney cancer	2.23e-05	0.000436	CbGpPWpGaD
Riluzole—Feeling abnormal—Doxorubicin—kidney cancer	2.23e-05	0.000105	CcSEcCtD
Riluzole—Gastrointestinal pain—Doxorubicin—kidney cancer	2.21e-05	0.000104	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—VEGFA—kidney cancer	2.21e-05	0.000431	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ALDH1A1—kidney cancer	2.18e-05	0.000426	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.17e-05	0.000423	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PDHB—kidney cancer	2.16e-05	0.000422	CbGpPWpGaD
Riluzole—CYP1A2—Biological oxidations—POMC—kidney cancer	2.15e-05	0.00042	CbGpPWpGaD
Riluzole—Urticaria—Doxorubicin—kidney cancer	2.15e-05	0.000101	CcSEcCtD
Riluzole—Body temperature increased—Doxorubicin—kidney cancer	2.14e-05	0.000101	CcSEcCtD
Riluzole—Abdominal pain—Doxorubicin—kidney cancer	2.14e-05	0.000101	CcSEcCtD
Riluzole—CYP1A1—Metabolism—SLC5A3—kidney cancer	2.09e-05	0.000409	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PGK1—kidney cancer	2.09e-05	0.000409	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—MAPK3—kidney cancer	2.09e-05	0.000407	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ITPR2—kidney cancer	2.08e-05	0.000406	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—LDHB—kidney cancer	2.05e-05	0.000401	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CCBL1—kidney cancer	2.03e-05	0.000397	CbGpPWpGaD
Riluzole—Hypersensitivity—Doxorubicin—kidney cancer	1.99e-05	9.38e-05	CcSEcCtD
Riluzole—SCN5A—Developmental Biology—MAPK1—kidney cancer	1.98e-05	0.000388	CbGpPWpGaD
Riluzole—Asthenia—Doxorubicin—kidney cancer	1.94e-05	9.14e-05	CcSEcCtD
Riluzole—Pruritus—Doxorubicin—kidney cancer	1.91e-05	9.01e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—ACHE—kidney cancer	1.9e-05	0.00037	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTT1—kidney cancer	1.9e-05	0.00037	CbGpPWpGaD
Riluzole—SCN5A—Developmental Biology—KRAS—kidney cancer	1.87e-05	0.000366	CbGpPWpGaD
Riluzole—Diarrhoea—Doxorubicin—kidney cancer	1.85e-05	8.71e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.84e-05	0.000359	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SCARB1—kidney cancer	1.79e-05	0.00035	CbGpPWpGaD
Riluzole—Dizziness—Doxorubicin—kidney cancer	1.79e-05	8.42e-05	CcSEcCtD
Riluzole—CYP1A1—Metabolism—CA9—kidney cancer	1.78e-05	0.000347	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS1—kidney cancer	1.78e-05	0.000347	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PPAT—kidney cancer	1.76e-05	0.000344	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.76e-05	0.000344	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PSMD7—kidney cancer	1.74e-05	0.00034	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.74e-05	0.000339	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.72e-05	0.000336	CbGpPWpGaD
Riluzole—Vomiting—Doxorubicin—kidney cancer	1.72e-05	8.1e-05	CcSEcCtD
Riluzole—Rash—Doxorubicin—kidney cancer	1.7e-05	8.03e-05	CcSEcCtD
Riluzole—Dermatitis—Doxorubicin—kidney cancer	1.7e-05	8.02e-05	CcSEcCtD
Riluzole—Headache—Doxorubicin—kidney cancer	1.69e-05	7.98e-05	CcSEcCtD
Riluzole—ABCG2—Metabolism—BCHE—kidney cancer	1.65e-05	0.000322	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—APRT—kidney cancer	1.64e-05	0.00032	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—FH—kidney cancer	1.64e-05	0.00032	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC5A5—kidney cancer	1.63e-05	0.000318	CbGpPWpGaD
Riluzole—Nausea—Doxorubicin—kidney cancer	1.6e-05	7.56e-05	CcSEcCtD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.6e-05	0.000312	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—SLC2A1—kidney cancer	1.58e-05	0.000308	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GPC3—kidney cancer	1.54e-05	0.000301	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—CRABP1—kidney cancer	1.51e-05	0.000295	CbGpPWpGaD
Riluzole—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	1.5e-05	0.000293	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA2—kidney cancer	1.5e-05	0.000292	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALAD—kidney cancer	1.46e-05	0.000285	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.42e-05	0.000278	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ITPR2—kidney cancer	1.41e-05	0.000275	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.39e-05	0.000272	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PGK1—kidney cancer	1.33e-05	0.000261	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.33e-05	0.000261	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTP1—kidney cancer	1.31e-05	0.000256	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—LDHB—kidney cancer	1.31e-05	0.000256	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.3e-05	0.000253	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTT1—kidney cancer	1.28e-05	0.00025	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ACHE—kidney cancer	1.28e-05	0.00025	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—ABCB1—kidney cancer	1.24e-05	0.000243	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SCARB1—kidney cancer	1.21e-05	0.000237	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—GSTM1—kidney cancer	1.21e-05	0.000236	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS1—kidney cancer	1.2e-05	0.000235	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PSMD7—kidney cancer	1.18e-05	0.00023	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—CYP1A1—kidney cancer	1.14e-05	0.000223	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CA9—kidney cancer	1.13e-05	0.000222	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—BCHE—kidney cancer	1.12e-05	0.000218	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.11e-05	0.000217	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC5A5—kidney cancer	1.1e-05	0.000216	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—SLC2A1—kidney cancer	1.07e-05	0.000208	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.03e-05	0.000202	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CRABP1—kidney cancer	9.65e-06	0.000188	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	9.02e-06	0.000176	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ITPR2—kidney cancer	8.97e-06	0.000175	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTP1—kidney cancer	8.89e-06	0.000174	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—POMC—kidney cancer	8.53e-06	0.000167	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—ABCB1—kidney cancer	8.42e-06	0.000164	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.27e-06	0.000161	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ACHE—kidney cancer	8.18e-06	0.00016	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTT1—kidney cancer	8.18e-06	0.00016	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—GSTM1—kidney cancer	8.17e-06	0.00016	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SCARB1—kidney cancer	7.74e-06	0.000151	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS1—kidney cancer	7.67e-06	0.00015	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PSMD7—kidney cancer	7.52e-06	0.000147	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—BCHE—kidney cancer	7.13e-06	0.000139	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC5A5—kidney cancer	7.04e-06	0.000137	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTGS2—kidney cancer	6.81e-06	0.000133	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—SLC2A1—kidney cancer	6.8e-06	0.000133	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.6e-06	0.000129	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.36e-06	0.000124	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PTEN—kidney cancer	5.94e-06	0.000116	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—POMC—kidney cancer	5.78e-06	0.000113	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.75e-06	0.000112	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTP1—kidney cancer	5.67e-06	0.000111	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—ABCB1—kidney cancer	5.37e-06	0.000105	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—GSTM1—kidney cancer	5.21e-06	0.000102	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—CYP1A1—kidney cancer	4.94e-06	9.64e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTGS2—kidney cancer	4.61e-06	8.99e-05	CbGpPWpGaD
Riluzole—ABCG2—Metabolism—PIK3CA—kidney cancer	4.19e-06	8.18e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.06e-06	7.92e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PTEN—kidney cancer	4.02e-06	7.84e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—POMC—kidney cancer	3.68e-06	7.19e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTGS2—kidney cancer	2.94e-06	5.74e-05	CbGpPWpGaD
Riluzole—CYP1A1—Metabolism—PIK3CA—kidney cancer	2.83e-06	5.53e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PTEN—kidney cancer	2.56e-06	5e-05	CbGpPWpGaD
Riluzole—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.81e-06	3.53e-05	CbGpPWpGaD
